| HEC business school, MBA |
Prior to founding SpePharm Jean-François Labbé was an investor in and CEO of OTL Pharma, a Paris-based specialty pharmaceutical and orphan drug company, which achieved €14M sales in 2004, the year he sold the business to Strakan (now ProStrakan). Jean-François has worked for over 30 years in the pharmaceutical industry and was previously CEO of Parke Davis France. Prior to joining Parke Davis, Jean-François worked for Hoechst-Roussel for 25 years where he held various general management positions in Europe (The Netherlands, France, UK) and abroad (USA, South Africa).
